Blackstone’s life sciences-focused real estate unit plans to purchase a 2.3 million square foot portfolio of lab office buildings from Brookfield Asset Management’s real estate fund for $3.45 billion.
The transaction is slated to close next quarter and represents a sizable move into the Boston/Cambridge market that will make Blackstone the largest life science office owner in the area.
Blackstone Property Partners Life Sciences is a distinct segment of Blackstone’s existing $174 billion real estate business in that it is a long-term, perpetual capital vehicle that is . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.
